Angiotensin II mediates postischemic leukocyte-endothelial interactions: role of calcitonin gene-related peptide.

Angiotensin II mediates postischemic leukocyte-endothelial interactions: role of calcitonin gene-related peptide.
复制标题

DOI:
10.1152/ajpheart.01210.2006
复制
发表时间:
2007-06
期刊:
American journal of physiology. Heart and circulatory physiology
影响因子:
--
通讯作者:
M. Yusof;Kazuhiro Kamada;F. Gaskin;R. Korthuis;Yusof M;Kamada K;Gaskin Fs;Korthuis Rj Angiotensin;J. Korthuis
M. Yusof;Kazuhiro Kamada;F. Gaskin;R. Korthuis;Yusof M;Kamada K;Gaskin Fs;Korthuis Rj Angiotensin;J. Korthuis
中科院分区:
其他
文献类型:
--
作者:
M. Yusof;Kazuhiro Kamada;F. Gaskin;R. Korthuis;Yusof M;Kamada K;Gaskin Fs;Korthuis Rj Angiotensin;J. Korthuis

文献摘要

被引文献

相似文献

Vascular inflammation and enhanced production of angiotensin II (ANG II) are involved in the pathogenesis of hypertension and diabetes, disease states that predispose the afflicted individuals to ischemic disorders. In light of these observations, we postulated that ANG II may play a role in promoting leukocyte rolling (LR) and adhesion (LA) in postcapillary venules after exposure of the small intestine to ischemia-reperfusion (I/R). Using an intravital microscopic approach in C57BL/6J mice, we showed that ANG II type I (AT(1)) or type II (AT(2)) receptor antagonism (with valsartan or PD-123319, respectively), inhibition of angiotensin-converting enzyme (ACE) with captopril, or calcitonin gene-related peptide (CGRP) receptor blockade (CGRP8-37) prevented postischemic LR but did not influence I/R-induced LA. However, both postischemic LR and LA were largely abolished by concomitant AT(1) and AT(2) receptor blockade or chymase inhibition (with Y-40079). Additionally, exogenously administered ANG II increased LR and LA, effects that were attenuated by pretreatment with a CGRP receptor antagonist or an NADPH oxidase inhibitor (apocynin). Our work suggests that ANG II, formed by the enzymatic activity of ACE and chymase, plays an important role in inducing postischemic LR and LA, effects that involve the engagement of both AT(1) and AT(2) receptors and may be mediated by CGRP and NADPH oxidase.